5 ms·
Phase 3 trials don’t cost $1B - they’re more on the order of $20M.
by mikeyouse 1y ago
Phase 3 trials don’t cost $1B - they’re more on the order of $20M.
- nradov 1y agoSorry I should have been more specific. Average total cost to bring a new drug to market is on the order of $2B. https://www.fiercebiotech.com/biotech/drug-development-cost-pharma-22b-asset-2024-plus-how-glp-1s-impact-roi-deloitte https://www.fiercebiotech.com/biotech/drug-development-cost-...
- throwawaymaths 1y agoyes, that includes failures, which includes shit that a beginning grad student could tell you wouldn't work.